Department of Surgery, Institute of Innovative Cancer Research, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Ann Surg Oncol. 2013 Sep;20(9):2914-20. doi: 10.1245/s10434-013-2919-4. Epub 2013 Jun 13.
To evaluate stage IIA colorectal cancer in terms of recurrence so as to discover whether high preoperative serum carcinoembryonic antigen (s-CEA) levels indicate that the patient should be included in a high-risk group in stage II colorectal cancer.
We retrospectively reviewed the records of 1543 patients with stage IIA colorectal cancer who underwent curative surgery between January 2000 and December 2007.
The 5-year disease-free survival and overall survival rates were significantly lower in patients with a higher than normal preoperative s-CEA (90.5% vs. 82.5%, P<0.001, and 92.4% vs. 87.8%, P=0.034, respectively). Multivariate analysis revealed that elevated preoperative s-CEA level, preoperative obstruction, rectal cancer, and dissection of fewer than 12 nodes were independent statistically significant prognostic factors that predicted disease-free survival in patients with stage IIA disease after curative resection.
Elevated preoperative s-CEA concentration is a reliable predictor of recurrence after curative resection in patients with stage IIA colorectal cancer. Patients with stage IIA disease with elevated preoperative s-CEA level do worse than those with normal levels and might constitute a group to evaluate for adjuvant chemotherapy. Further studies on the effect of adjuvant chemotherapy in this group are needed.
评估 IIA 期结直肠癌的复发情况,以发现术前高血清癌胚抗原(s-CEA)水平是否表明患者应被归入 II 期结直肠癌的高危组。
我们回顾性分析了 2000 年 1 月至 2007 年 12 月期间接受根治性手术的 1543 例 IIA 期结直肠癌患者的记录。
术前 s-CEA 高于正常水平的患者 5 年无病生存率和总生存率显著降低(90.5%比 82.5%,P<0.001,92.4%比 87.8%,P=0.034)。多因素分析显示,术前 s-CEA 水平升高、术前梗阻、直肠癌和清扫淋巴结少于 12 个是独立的统计学显著预后因素,预测 IIA 期疾病患者根治性切除术后的无病生存。
术前 s-CEA 浓度升高是 IIA 期结直肠癌根治性切除术后复发的可靠预测指标。术前 s-CEA 水平升高的 IIA 期疾病患者比正常水平患者预后更差,可能构成评估辅助化疗的一个组。需要进一步研究该组辅助化疗的效果。